Inicio › Dermatitis atópica (eccema) › Misuri
Ensayos clínicos de Dermatitis atópica (eccema) en Misuri
7 estudios sobre Dermatitis atópica (eccema) buscan participantes en Misuri.
Texto oficial del estudio (inglés)
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Red River Research Partners, Llc- Site Number : 8400054, Bolivar
- Cleaver Dermatology- Site Number : 8400033, Kirksville
ReclutandoEstudio observacional
Edades de 12 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT07290803Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Saint Joseph
ReclutandoFase 2
Edades de 18 a 100 · Todos los sexos · Actualizado el 28 sept 2026 · NCT06947993A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Saint Louis University, St Louis
ReclutandoFase 3
Edades de 2 a 11 · Todos los sexos · Actualizado el 25 sept 2026 · NCT06807281Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
- U.S. Dermatology Partners Lee's Summit, Lee's Summit
ReclutandoEstudio observacional
Edades de 12 a 89 · Todos los sexos · Actualizado el 15 sept 2026 · NCT07645820A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- Washington University School of Medicine - St. Louis /ID# 268545, St Louis
ReclutandoFase 3
Edades de 2 a 11 · Todos los sexos · Actualizado el 6 ago 2026 · NCT06461897A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- MediSearch Clinical Trials /ID# 263579, Saint Joseph
ReclutandoFase 3
Edades de 18 a 63 · Todos los sexos · Actualizado el 6 jul 2026 · NCT06389136Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 7057, Lee's Summit
ReclutandoEstudio observacional
Edades de 12 en adelante · Todos los sexos · Actualizado el 13 mar 2026 · NCT06988605De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.